Elizabeth Arden, Inc. Announces First Quarter Fiscal 2010 Results




                           Net Sales of $265 Million
                   GAAP EPS of $0.00; Adjusted EPS of $0.05 
              --------------------------------------------------

NEW YORK, Oct. 29, 2009 (GLOBE NEWSWIRE) -- Elizabeth Arden, Inc. (Nasdaq:RDEN), a global prestige beauty products company, today announced financial results for its first fiscal quarter ended September 30, 2009.

FIRST QUARTER RESULTS

For the quarter ended September 30, 2009, the Company reported net sales of $265.2 million, a decrease of 6.7%, as compared to the first quarter of the prior fiscal year. Excluding the unfavorable impact of foreign currency translation, net sales decreased by 5.0%.

Net income per diluted share for the first fiscal quarter ended September 30, 2009 was $0.00, as compared to a net loss per diluted share of $0.45 for the prior year period. Excluding restructuring and other expenses associated with the Company's Global Efficiency Re-engineering initiative, net income per diluted share for the three months ended September 30, 2009 was $0.05, as compared to net income per diluted share of $0.11 for the prior year period. The prior year period also excludes expenses and non-cash charges related to the Liz Claiborne license agreement. A reconciliation between GAAP and adjusted results can be found in the tables and footnotes to this press release.

E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, "We are encouraged by our first quarter results, with each of our business units generally performing as we had expected. Sales results were at the high end of our expectations, and earnings exceeded prior guidance, aided by improved trends in the travel retail and distributor markets and more favorable foreign currency rates. We are particularly pleased with the progress we continue to make with our Global Efficiency Re-engineering initiative. Gross margins increased by 90 basis points this quarter, and we were able to reduce inventory by $105 million from September 2008 levels, resulting in a $92 million reduction in credit line and accounts payable balances."

Mr. Beattie continued, "There are signs that economic conditions are beginning to improve, and, while early, we are expecting good performance from our new launches for the holiday season. We are still not yet seeing, however, a return to normalized replenishment by our retailers, particularly in our North America fragrance business. While we expect the gap between retail sales and inventory replenishment to improve, it is difficult to predict the timing and magnitude of any improvement. We remain confident that with the success of our operational initiatives, an improvement in retailer replenishment should lead to accelerated growth in earnings and return on invested capital."

OUTLOOK

For the second quarter of fiscal 2010, the Company expects net sales of $380 million to $390 million and net income per diluted share of $0.65 to $0.75. The net sales guidance for the second fiscal quarter assumes a favorable impact from foreign currency translation of approximately 2.5% as compared to the prior year period.

The Company is updating its annual net sales and earnings guidance for the fiscal year ending June 30, 2010, and now expects a net sales increase of 2.5% to 3.5%, as compared to the prior fiscal year, and earnings per diluted share to be in the range of $0.55 to $0.65.

The guidance assumes October 2009 foreign currency rates and excludes restructuring and other expenses associated with the Company's Global Efficiency Re-engineering initiative. The Company notes that the high degree of ongoing global economic uncertainty may continue to have a negative effect on retailer and consumer confidence and demand, and, along with the foreign currency volatility, makes forecasting difficult. The Company believes that net sales and earnings guidance, excluding the impact of foreign currency and restructuring and other expenses associated with the Company's Global Efficiency Re-engineering initiative, as applicable, facilitates period to period comparisons of the Company's operating and financial performance on a consistent basis.

CONFERENCE CALL INFORMATION

The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company's conference call by visiting the "Corporate Info" section on the Company's web site at http://www.elizabetharden.com. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Company's web site until November 29, 2009.

Elizabeth Arden is a global prestige beauty products company with an extensive portfolio of prestige beauty brands sold in over 100 countries. The company's brand portfolio includes Elizabeth Arden skincare, color, and fragrance products, PREVAGE(R) anti-aging treatments, the celebrity fragrance brands of Elizabeth Taylor, Mariah Carey, Britney Spears, Hilary Duff, and Usher; the designer fragrance brands of Juicy Couture, Alberta Ferretti, Alfred Sung, Badgley Mischka, Bob Mackie, GANT, Geoffrey Beene, Liz Claiborne, Halston, Lucky Brand, Nanette Lepore and Rocawear; and the lifestyle fragrance brands Curve, Giorgio Beverly Hills, and PS Fine Cologne.



                ELIZABETH ARDEN, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF OPERATIONS DATA
                              (Unaudited)
         (In thousands, except percentages and per share data)


                                                  Three Months Ended
                                               -----------------------
                                                Sept. 30,    Sept. 30,
                                                  2009         2008
                                               ----------   ----------
 Net Sales                                     $  265,164   $  284,187
 Cost of Sales                                    148,277      177,773
                                               ----------   ----------
 Gross Profit                                     116,887      106,414
 Gross Profit Percentage                             44.1%        37.4%

 Selling, General and Administrative Expenses     103,943      109,388
 Depreciation and Amortization                      7,276        6,339
                                               ----------   ----------
 Total Operating Expenses                         111,219      115,727

 Interest Expense, Net                              5,611        6,575
                                               ----------   ----------
 Income (Loss) Before Income Taxes                     57      (15,888)
 Provision for (Benefit from) Income Taxes             17       (3,372)
                                               ----------   ----------
 Net Income (Loss)                             $       40   $  (12,516)
                                               ==========   ==========

 As reported:
 -----------
  Net Income (Loss) Per Basic and
   Diluted Share                               $     0.00   $    (0.45)

  Basic Shares                                     27,922       27,866
  Diluted Shares                                   28,484       27,866

  EBITDA (a)                                   $   12,944   $   (2,974)
  EBITDA margin                                       4.9%       (1.0)%

 Adjusted to exclude the effect of
  Liz Claiborne-related and Global Efficiency
 Re-engineering initiative and restructuring
  expenses, net of taxes (b)(c):
 --------------------------------------------

  Gross Profit                                 $  116,887   $  122,809
  Gross Profit Percentage                            44.1%        43.2%

  Net Income                                   $    1,453   $    3,128

  Net Income Per Basic and Diluted Share       $     0.05   $     0.11

  EBITDA (a)                                   $   14,960   $   17,256
  EBITDA margin                                       5.6%         6.1%
                                               ==========   ==========

 (a)  EBITDA is defined as net income plus the provision for income
      taxes (or net loss less benefit from income taxes), plus
      interest expense, plus depreciation and amortization. EBITDA
      should not be considered as an alternative to income (loss)
      from operations or net income (loss) (as determined in accordance
      with generally accepted accounting principles (GAAP)) as a
      measure of our operating performance or to net cash provided by
      operating, investing and financing activities (as determined in
      accordance with GAAP) or as a measure of our ability to meet
      cash needs. We believe that EBITDA is a measure commonly reported
      and widely used by investors and other interested parties as a
      measure of a company's operating performance and debt servicing
      ability because it assists in comparing performance on a
      consistent basis without regard to capital structure,
      depreciation and amortization or non-operating factors (such as
      historical cost). Accordingly, as a result of our capital
      structure, we believe EBITDA is a relevant measure. This
      information has been disclosed here to permit a more complete
      comparative analysis of our operating performance relative to
      other companies and of our debt servicing ability. EBITDA may
      not, however, be comparable in all instances to other similar
      types of measures. We have also disclosed EBITDA as adjusted to
      exclude the effect of Liz Claiborne-related and Global Efficiency
      Re-engineering initiative and restructuring expenses. This
      disclosure is being provided for comparability purposes
      because we believe it is meaningful to our investors and other
      interested parties to understand the EBITDA performance of the
      Company on a consistent basis without regard to the effect of Liz
      Claiborne-related and Global Efficiency Re-engineering initiative
      and restructuring expenses. EBITDA margin represents EBITDA
      divided by Net Sales.

      The table below reconciles net income (loss), as determined in
      accordance with GAAP, to EBITDA and to EBITDA as adjusted:
      (For a reconciliation of net income (loss) to EBITDA for prior
      periods, see the Company's filings with the Securities and
      Exchange Commission which can be found on the Company's website
      at www.elizabetharden.com).


 (In thousands)                                   Three Months Ended
                                               -----------------------
                                                Sept. 30,    Sept. 30,
                                                  2009         2008
                                               ----------   ----------

 Net income (loss)                             $       40   $  (12,516)
 Plus:
  Provision for (benefit from) income taxes            17       (3,372)
  Interest expense, net                             5,611        6,575
  Depreciation and amortization                     7,276        6,339
                                               ----------   ----------
 EBITDA                                            12,944       (2,974)
 Liz Claiborne-related expenses (c)                    --       19,091
 Restructuring and other expenses (d)               2,016        1,139
                                               ----------   ----------
 EBITDA as adjusted                            $   14,960   $   17,256
                                               ==========   ==========


 (b)  The table below reconciles the calculation of (i) gross profit (ii)
      net income (loss) and (iii) net income (loss) per share on a basic
      and diluted basis from the amounts reported in accordance with GAAP
      to such amounts before giving effect to Liz Claiborne-related and 
      Global Efficiency Re-Engineering initiative and restructuring 
      expenses.  This disclosure is being provided for comparability
      purposes because we believe it is meaningful to our investors and
      other interested parties to understand the Company's operating
      performance on a consistent basis without regard to the effect of
      Liz Claiborne-related and Global Efficiency Re-Engineering 
      initiative and restructuring expenses.  The presentation in the
      table below of the non-GAAP information titled "Gross profit as
      adjusted" and "Net income as adjusted" and "Net income per basic and
      diluted share as adjusted" is not meant to be considered in
      isolation or as a substitute for gross profit, net income (loss) or
      net income (loss) per basic and diluted share prepared in accordance
      with GAAP.


 (In thousands, except per share data)            Three Months Ended
                                               -----------------------
                                                Sept. 30,    Sept. 30,
                                                  2009         2008
                                               ----------   ----------

 Adjusted to exclude the effect of Liz
  Claiborne-related and Global Efficiency
 Re-Engineering initiative and restructuring
  expenses
 --------------------------------------------

 Gross Profit:
 -------------
  Gross profit as reported                     $  116,887   $  106,414
  Liz Claiborne-related expenses (c)                    -       16,395
                                               ----------   ----------
  Gross profit as adjusted                     $  116,887   $  122,809
                                               ==========   ==========

 Net Income (Loss) (e):
 ----------------------
  Net income (loss) as reported                $       40   $  (12,516)
  Liz Claiborne-related expenses, net
   of tax (c)                                          --       14,763
  Restructuring and Global Efficiency
   Re-Engineering initiative expenses,
   net of tax (d)                                   1,413          881
                                               ----------   ----------
  Net income as adjusted                       $    1,453   $    3,128
                                               ==========   ==========

 Net Income (Loss) Per Basic And
  Diluted Share (e):
 -------------------------------
  Net income (loss) per basic and diluted
   share as reported                           $     0.00   $    (0.45)
  Liz Claiborne-related and Global Efficiency
   Re-Engineering initiative and restructuring
   expenses, net of tax (c) (d)                      0.05         0.56
                                               ----------   ----------
  Net income per basic and diluted share
   as adjusted                                 $     0.05   $     0.11
                                               ==========   ==========


 (c)  For the three months ended September 30, 2008, includes $3.7 million
      of Liz Claiborne transition expenses and $15.4 million of non-cash
      expenses relating to Liz Claiborne inventory purchased by the 
      Company at a higher cost prior to the effective date of the license
      agreement.  Approximately $1.0 million of transition expenses are
      included in cost of sales.

 (d)  For the three months ended September 30, 2009, includes $0.6 million
      related to the implementation of our Oracle accounting and order
      processing systems, $1.0 million of restructuring expenses related
      to our Global Efficiency Re-engineering initiative and $0.4 million
      of restructuring expense not related to our Global Efficiency
      Re-engineering initiative. For the three months ended September 30,
      2008, includes $0.2 million related to the implementation of our
      Oracle accounting and order processing systems and $0.9 million of
      restructuring expenses related to our Global Efficiency
      Re-engineering initiative.

 (e)  On a reported basis, for the three months ended September 30, 2009
      and 2008, our effective tax rate, which is calculated as a
      percentage of income (loss) before income taxes, was 31.2% and
      21.2%, respectively. On an adjusted basis, for the three months
      ended September 30, 2009 and 2008, our effective tax rate was 29.9%
      and 28.0%, respectively.


                          SEGMENT NET SALES
                              (Unaudited)

 The table below is a comparative summary of our net sales by
 reportable segment for the three months ended September 30, 2009 and
 2008:

 (In thousands)                                   Three Months Ended
                                               ----------   ----------
                                                Sept. 30,    Sept. 30,
                                                  2009         2008
                                               ----------   ----------
 Segment Net Sales:
  North America Fragrance                      $  168,133   $  177,560
  International                                    85,228       94,426
  Other                                            11,803       12,201
                                               ----------   ----------
 Total                                         $  265,164   $  284,187
                                               ==========   ==========



                ELIZABETH ARDEN, INC. AND SUBSIDIARIES
                    CONSOLIDATED BALANCE SHEET DATA
                              (Unaudited)
                            (In thousands)

                                   Sept. 30,    June 30,     Sept. 30,
                                     2009         2009         2008
                                  ----------   ----------   ----------
 Cash                             $   23,495   $   23,102   $   27,518
 Accounts Receivable, Net            269,611      190,273      290,723
 Inventories                         353,268      318,535      458,711
 Property and Equipment, Net          64,359       64,110       50,714
 Exclusive Brand Licenses,
  Trademarks and Intangibles,
  Net                                206,263      207,375      220,785
 Total Assets                        997,564      879,087    1,109,191
 Short-Term Debt                     184,900      115,000      229,500
 Current Portion of
  Long-Term Debt                          --          545        1,205
 Current Liabilities                 422,060      307,126      531,006
 Long-Term Liabilities               235,405      235,183      243,418
 Total Debt                          408,341      338,911      453,856
 Shareholders' Equity                340,099      336,778      334,767
 Working Capital                     289,598      286,612      300,549



                  SUPPLEMENTARY CASH FLOW INFORMATION
                              (Unaudited)
                            (In thousands)

                                                  Three Months Ended
                                               -----------------------
                                                Sept. 30,    Sept. 30,
                                                  2009         2008
                                               ----------   ----------
 Net cash used in operating
  activities                                   $  (59,901)  $  (94,539)
 Net cash used in investing
  activities                                       (9,159)     (12,888)
 Net cash provided by financing
  activities                                       68,971      109,431
 Net increase in cash and cash
  equivalents                                         393        1,122

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "should," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding net sales and earnings and returns on invested capital, and the costs, savings and benefits we expect in connection with our Global Efficiency Re-engineering initiative and related restructuring plan. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:



 * factors affecting our relationships with our customers or our
   customers' businesses, including the absence of contracts with
   customers, our customers' financial condition, and changes in
   the retail, fragrance and cosmetic industries, such as the
   consolidation of retailers and the associated closing of retail
   doors as well as retailer inventory control practices,
   including, but not limited to levels of inventory carried at
   point of sale and practices used to control inventory
   shrinkage;
 * risks of international operations, including foreign currency
   fluctuations, hedging activities, economic and political
   consequences of terrorist attacks, unfavorable changes in U.S.
   or international tax laws or regulations, diseases and pandemics
   and political instability in certain regions of the world;
 * our reliance on third-party manufacturers for substantially all
   of our owned and licensed products and our absence of contracts
   with suppliers of distributed brands and components for
   manufacturing of owned and licensed brands;
 * delays in shipments, inventory shortages and higher costs of
   production due to the loss of or disruption in our distribution
   facilities or at key third party manufacturing or fulfillment
   facilities that manufacture or provide logistic services for our
   products;
 * our ability to respond in a timely manner to changing consumer
   preferences and purchasing patterns and other international and
   domestic conditions and events that impact consumer confidence
   and demand, such as the current global recession;
 * our ability to protect our intellectual property rights;
 * the success, or changes in the timing or scope, of our new
   product launches, advertising and merchandising programs;
 * the quality, safety and efficacy of our products;
 * the impact of competitive products and pricing;
 * our ability to (i) implement our growth strategy and acquire or
   license additional brands or secure additional distribution
   arrangements, (ii) successfully and cost-effectively integrate
   acquired businesses or new brands, and (iii) finance our growth
   strategy and our working capital requirements;
 * our level of indebtedness, our ability to realize sufficient
   cash flow from operations to meet our debt service obligations
   and working capital requirements and the restrictive covenants
   in our revolving credit facility and the indenture for our 
   7 3/4% senior subordinated notes;
 * changes in product mix to less profitable products;
 * the retention and availability of key personnel;
 * changes in the legal, regulatory and political environment that
   impact, or will impact, our business, including changes to
   customs or trade regulations or accounting standards or critical
   accounting estimates;
 * the success of, and costs associated with, our Global Efficiency
   Re-engineering initiative and related restructuring plan,
   including our transition to a turnkey manufacturing process and
   implementation of our new Oracle financial accounting and order
   processing system;
 * the potential for significant impairment charges relating to our
   trademark, goodwill or other long-lived assets that could result
   from a number of factors, including downward pressure on our
   stock price; and
 * other unanticipated risks and uncertainties.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended June 30, 2009.


            

Contact Data